Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (411-420 of 682) with videos related to

Pageof 69
Sort By:
International Journal of Antimicrobial Agents|April 18, 2013
Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drainsSyamhanin Adnan, Janice Xuanhui Li, Steven C Wallis, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2013
A new regimen for continuous infusion of vancomycin during continuous renal replacement therapyMarjorie Beumier, Jason A Roberts, Hakim Kabtouri, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients with an Indwelling External Ventricular DrainFekade B Sime, Melissa Lassig-Smith, Therese Starr, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2019
Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal DysfunctionFekade B Sime, Melissa Lassig-Smith, Therese Starr, et al.
Anaesthesia, Critical Care & Pain Medicine|August 14, 2023
Efficiency of dosing software using Bayesian forecasting in achieving target antibiotic exposures in critically ill patients, a prospective cohort studyMing G Chai, Jason A Roberts, Christina F Kelly, et al.
Trials|June 8, 2019
Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trialStefan Hagel, Sandra Fiedler, Andreas Hohn, et al.
Pharmacotherapy|May 8, 2020
Pharmacokinetics of Sulfamethoxazole and Trimethoprim During Venovenous Extracorporeal Membrane Oxygenation: A Case ReportJayesh A Dhanani, Jeffrey Lipman, Jason Pincus, et al.
Antimicrobial Agents and Chemotherapy|October 31, 2024
Continuous infusion of piperacillin/tazobactam optimizes intraoperative antibiotic exposure in patients undergoing elective pelvic exenteration surgeryDwane Jackson, Marta Ulldemolins, Xin Liu, et al.
Antimicrobial Agents and Chemotherapy|August 5, 2015
Population Pharmacokinetics of Fosfomycin in Critically Ill PatientsSuzanne L Parker, Frantzeska Frantzeskaki, Steven C Wallis, et al.
Jac-Antimicrobial Resistance|May 14, 2025
Evaluation of the stability of tigecycline in elastomeric infusion devices used for outpatient parenteral antimicrobial therapyZenaw T Wolie, Sean Unwin, Andrew Burke, et al.
Pageof 69

Showing results (411-420 of 682) with videos related to

Sort By:
Pageof 69
International Journal of Antimicrobial Agents|April 18, 2013
Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drainsSyamhanin Adnan, Janice Xuanhui Li, Steven C Wallis, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2013
A new regimen for continuous infusion of vancomycin during continuous renal replacement therapyMarjorie Beumier, Jason A Roberts, Hakim Kabtouri, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients with an Indwelling External Ventricular DrainFekade B Sime, Melissa Lassig-Smith, Therese Starr, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2019
Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal DysfunctionFekade B Sime, Melissa Lassig-Smith, Therese Starr, et al.
Anaesthesia, Critical Care & Pain Medicine|August 14, 2023
Efficiency of dosing software using Bayesian forecasting in achieving target antibiotic exposures in critically ill patients, a prospective cohort studyMing G Chai, Jason A Roberts, Christina F Kelly, et al.
Trials|June 8, 2019
Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trialStefan Hagel, Sandra Fiedler, Andreas Hohn, et al.
Pharmacotherapy|May 8, 2020
Pharmacokinetics of Sulfamethoxazole and Trimethoprim During Venovenous Extracorporeal Membrane Oxygenation: A Case ReportJayesh A Dhanani, Jeffrey Lipman, Jason Pincus, et al.
Antimicrobial Agents and Chemotherapy|October 31, 2024
Continuous infusion of piperacillin/tazobactam optimizes intraoperative antibiotic exposure in patients undergoing elective pelvic exenteration surgeryDwane Jackson, Marta Ulldemolins, Xin Liu, et al.
Antimicrobial Agents and Chemotherapy|August 5, 2015
Population Pharmacokinetics of Fosfomycin in Critically Ill PatientsSuzanne L Parker, Frantzeska Frantzeskaki, Steven C Wallis, et al.
Jac-Antimicrobial Resistance|May 14, 2025
Evaluation of the stability of tigecycline in elastomeric infusion devices used for outpatient parenteral antimicrobial therapyZenaw T Wolie, Sean Unwin, Andrew Burke, et al.
Pageof 69